[go: up one dir, main page]

DK399288D0 - DOUBLE-STRENGTH RNA CORRECTION OF ABNORMITIES IN CIRCULATING IMMUNE COMPLEXES AND MONOCYTY FUNCTION - Google Patents

DOUBLE-STRENGTH RNA CORRECTION OF ABNORMITIES IN CIRCULATING IMMUNE COMPLEXES AND MONOCYTY FUNCTION

Info

Publication number
DK399288D0
DK399288D0 DK399288A DK399288A DK399288D0 DK 399288 D0 DK399288 D0 DK 399288D0 DK 399288 A DK399288 A DK 399288A DK 399288 A DK399288 A DK 399288A DK 399288 D0 DK399288 D0 DK 399288D0
Authority
DK
Denmark
Prior art keywords
double
immune complexes
monocyty
abnormities
strength
Prior art date
Application number
DK399288A
Other languages
Danish (da)
Other versions
DK399288A (en
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK399288D0 publication Critical patent/DK399288D0/en
Publication of DK399288A publication Critical patent/DK399288A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The use of a double-stranded RNA for the manufacture of a medicament for treating an inflammatory disorder characterised by elevated levels of circulating immune complexes in the patient's blood.
DK399288A 1987-07-17 1988-07-15 DOUBLE-STRENGTH RNA CORRECTION OF ABNORMITIES IN CIRCULATING IMMUNE COMPLEXES AND MONOCYTY FUNCTION DK399288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (2)

Publication Number Publication Date
DK399288D0 true DK399288D0 (en) 1988-07-15
DK399288A DK399288A (en) 1989-01-18

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK399288A DK399288A (en) 1987-07-17 1988-07-15 DOUBLE-STRENGTH RNA CORRECTION OF ABNORMITIES IN CIRCULATING IMMUNE COMPLEXES AND MONOCYTY FUNCTION

Country Status (18)

Country Link
EP (1) EP0300680B1 (en)
JP (1) JP2601520B2 (en)
KR (1) KR0131880B1 (en)
CN (1) CN1035050A (en)
AT (1) ATE142500T1 (en)
AU (2) AU1820588A (en)
CA (1) CA1326999C (en)
DE (1) DE3855527T2 (en)
DK (1) DK399288A (en)
ES (1) ES2093607T3 (en)
FI (1) FI883352A (en)
HU (1) HUT47432A (en)
IE (1) IE76914B1 (en)
IL (1) IL86862A (en)
NO (1) NO175023C (en)
NZ (1) NZ225310A (en)
OA (1) OA08890A (en)
PT (1) PT87996B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
AU2268892A (en) * 1991-07-16 1993-02-23 Hem Pharmaceuticals Corp. Modulation and diagnosis of cytokine dysfunctions
FR2768344B1 (en) * 1997-08-26 2001-02-16 Scras PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE
FR2768345B1 (en) * 1997-09-17 2001-05-04 Scras PRODUCT COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF A VIRAL HEPATITIS
FR2766715B1 (en) * 1997-08-04 2001-02-16 Scras PRODUCT INCLUDING AT LEAST DOUBLE-STRANDED RNA IN ASSOCIATION WITH AT LEAST ONE ANTI-VIRAL AGENT FOR SIMULTANEOUS THERAPEUTIC USE, SEPARATE OR OVER TIME, IN THE TREATMENT OF A VIRAL DISEASE
AR013269A1 (en) * 1997-08-04 2000-12-13 Scras PRODUCT CONTAINING AT LEAST A DOUBLE FILAMENT RNA COMBINED WITH AT LEAST AN ANTI-VIRAL AGENT, FOR THERAPEUTIC USE IN THE TREATMENT OF A VIRAL DISEASE, ESPECIALLY OF VIRAL HEPATITIS
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
ES2374534T3 (en) 1998-03-20 2012-02-17 Commonwealth Scientific And Industrial Research Organisation GENES EXPRESSION CONTROL.
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
EP2351577A1 (en) * 2004-12-29 2011-08-03 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
ES2755418T3 (en) * 2015-11-17 2020-04-22 Bioncotech Therapeutics S L Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine
CN105434341B (en) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 A kind of polyadenylic-polyuridylic acid parenteral solution for animals and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
KR890001580A (en) 1989-03-27
CA1326999C (en) 1994-02-15
EP0300680A3 (en) 1991-06-19
PT87996A (en) 1989-06-30
CN1035050A (en) 1989-08-30
IL86862A (en) 1993-05-13
AU1761195A (en) 1995-06-29
FI883352A0 (en) 1988-07-14
DK399288A (en) 1989-01-18
JPS6490126A (en) 1989-04-06
EP0300680A2 (en) 1989-01-25
IL86862A0 (en) 1988-11-30
IE881894L (en) 1989-01-17
ES2093607T3 (en) 1997-01-01
HUT47432A (en) 1989-03-28
NO882853D0 (en) 1988-06-28
NO175023B (en) 1994-05-09
DE3855527T2 (en) 1997-04-03
OA08890A (en) 1989-10-31
KR0131880B1 (en) 1998-04-17
NO175023C (en) 1994-08-17
EP0300680B1 (en) 1996-09-11
ATE142500T1 (en) 1996-09-15
NZ225310A (en) 1991-05-28
PT87996B (en) 1995-03-31
NO882853L (en) 1989-01-18
FI883352A (en) 1989-01-18
AU1820588A (en) 1989-01-19
IE76914B1 (en) 1997-11-05
DE3855527D1 (en) 1996-10-17
JP2601520B2 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
DK399288A (en) DOUBLE-STRENGTH RNA CORRECTION OF ABNORMITIES IN CIRCULATING IMMUNE COMPLEXES AND MONOCYTY FUNCTION
ATE169219T1 (en) TREATMENT OF CATARACT WITH 15-KETO PROSTAGLAND INDERIVATIVES
DK465488A (en) PHARMACEUTICAL PREPARATION CONTAINING A TRIAZOL COMPOUND
DE69130586D1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin E derivatives
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE22655T1 (en) INFUSION SOLUTIONS FOR CARDIAC THERAPY.
DE69007065D1 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
DK0430551T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DK0458537T3 (en) Use of a therapeutic compound for the treatment of bronchitis
TW217382B (en)
ITMI931777A0 (en) NEW AGENTS FOR EXTRACORPOREAL BLOOD OXYGENATION
ATE98127T1 (en) USE OF PEROXIDE LIPIDES IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF CIRCULATORY FAILURE BY LOCAL APPLICATION.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment